Project
STORM: A randomized phase II Trial for the Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases
Ongoing - recruitment closed ยท 2019 until 2025
Putora Paul Martin
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Ongoing - recruitment closed
Start Date
2019
End Date
2025
Financing
Others
Study Design
Multicenter, randomized Phase II
Partner
Research sites: Belgium and Switzerland
Planned Sites: Norway. Netherlands, Germany, Spain, Italy and australia
Brief description/objective
To compare metastases-free survival (MFS) between metastasis-directed therapy and metastases-directed therapy with whole pelvis radiotherapy for oligorecurrent nodal prostate cancer.
Target: 178 Patients